|
1
|
Antoniades C, Antonopoulos AS, Bendall JK
and Channon KM: Targeting redox signaling in the vascular wall:
from basic science to clinical practice. Curr Pharm Des.
15:329–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol
(Oxf). 214:33–50. 2015. View Article : Google Scholar
|
|
4
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao XY and Lin JD: Long Noncoding RNAs: a
new regulatory code in metabolic control. Trends Biochem Sci.
40:586–596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Zheng L, Wang Q and Hu YW: Emerging
roles and mechanisms of long noncoding RNAs in atherosclerosis. Int
J Cardiol. 228:570–582. 2017. View Article : Google Scholar
|
|
8
|
Ballantyne MD, Pinel K, Dakin R, Vesey AT,
Diver L, Mackenzie R, Garcia R, Welsh P, Sattar N, Hamilton G, et
al: Smooth muscle enriched long noncoding RNA (SMILR) regulates
cell proliferation. Circulation. 133:2050–2065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shan K, Jiang Q, Wang XQ, Wang YN, Yang H,
Yao MD, Liu C, Li XM, Yao J, Liu B, et al: Role of long non-coding
RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell
Death Dis. 7:e22482016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui HB, Ge HE, Wang YS and Bai XY:
MiR-208a enhances cell proliferation and invasion of gastric cancer
by targeting SFRP1 and negatively regulating MEG3. Int J Biochem
Cell Biol. 102:31–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng Q, Lin Z, Xu J, Lu Y, Meng Q, Wang
C, Yang Y, Xin X, Li X, Pu H, et al: Long noncoding RNA MEG3
suppresses liver cancer cells growth through inhibiting β-catenin
by activating PKM2 and inactivating PTEN. Cell Death Dis.
9:2532018. View Article : Google Scholar
|
|
15
|
Sun Z, Nie X, Sun S, Dong S, Yuan C, Li Y,
Xiao B, Jie D and Liu Y: Long non-coding RNA MEG3 downregulation
triggers human pulmonary artery smooth muscle cell proliferation
and migration via the p53 signaling pathway. Cell Physiol Biochem.
42:2569–2581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Lin G and Zuo Z: Pharmacological
effects and pharmacokinetics properties of Radix Scutellariae and
its bioactive flavones. Biopharm Drug Dispos. 32:427–445. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ,
Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated
vascular smooth muscle cell proliferation through suppressing
PDGFRβ-ERK signaling and increase in p27 accumulation and prevents
injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu W, Jin Z, Yu J, Liang J, Yang Q, Li F,
Shi X, Zhu X and Zhang X: Baicalin ameliorates experimental
inflammatory bowel disease through polarization of macrophages to
an M2 phenotype. Int Immunopharmacol. 35:119–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Waisundara VY, Siu SY, Hsu A, Huang D and
Tan BK: Baicalin upregulates the genetic expression of antioxidant
enzymes in type-2 diabetic Goto-Kakizaki rats. Life Sci.
88:1016–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Ma L, Su M, Zhou Y, Mao K, Li C,
Peng G, Zhou C, Shen B and Dou J: Baicalin induces cellular
senescence in human colon cancer cells via upregulation of DEPP and
the activation of Ras/Raf/MEK/ERK signaling. Cell Death Dis.
9:2172018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang X, Zhang Q, Gao Z, Yu C and Zhang L:
Baicalin alleviates IL-1β-induced inflammatory injury via
down-regulating miR-126 in chondrocytes. Biomed Pharmacother.
99:184–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ku SK and Bae JS: Baicalin, baicalein and
wogonin inhibits high glucose-induced vascular inflammation in
vitro and in vivo. BMB Rep. 48:519–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu L, Liao P, Wang B, Fang X, Li W and
Guan S: Baicalin inhibits the expression of monocyte
chemoattractant protein-1 and interleukin-6 in the kidneys of
apolipoprotein E-knockout mice fed a high cholesterol diet. Mol Med
Rep. 11:3976–3980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guevara NV, Kim HS, Antonova EI and Chan
L: The absence of p53 accelerates atherosclerosis by increasing
cell proliferation in vivo. Nat Med. 5:335–339. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mercer J, Figg N, Stoneman V, Braganza D
and Bennett MR: Endogenous p53 protects vascular smooth muscle
cells from apoptosis and reduces atherosclerosis in ApoE knockout
mice. Circ Res. 96:667–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
el-Deiry WS, Tokino T, Velculescu VE, Levy
DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and
Vogelstein B: WAF1, a potential mediator of p53 tumor suppression.
Cell. 75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Cheng H, Yue Y, Li S, Zhang D and
He R: H19 knockdown suppresses proliferation and induces apoptosis
by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular
smooth muscle cells. J Biomed Sci. 25:112018. View Article : Google Scholar
|
|
28
|
Liu Y, Ma C, Zhang Q, Yu L, Ma J, Zhang L,
Hao X, Cao F, Wang L and Zhu D: The key role of transforming growth
factor-beta receptor I and 15-lipoxygenase in hypoxia-induced
proliferation of pulmonary artery smooth muscle cells. Int J
Biochem Cell Biol. 44:1184–1202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Liu Y, Cao Y, Sun S, Zhu J, Gao S, Pang J,
Zhu D and Sun Z: Transforming growth factor-beta1 upregulation
triggers pulmonary artery smooth muscle cell proliferation and
apoptosis imbalance in rats with hypoxic pulmonary hypertension via
the PTEN/AKT pathways. Int J Biochem Cell Biol. 77(Pt A): 141–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma J, Liang S, Wang Z, Zhang L, Jiang J,
Zheng J, Yu L, Zheng X, Wang R and Zhu D: ROCK pathway participates
in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE)
mediated the pulmonary vascular remodeling induced by hypoxia in
rat. J Cell Physiol. 222:82–94. 2010. View Article : Google Scholar
|
|
32
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm.
2013:1527862013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang Y, Xu Q, Peng H, Liu Z, Yang T, Yu Z,
Cheng G, Li X, Zhang G and Shi R: The role of vascular peroxidase 1
in ox-LDL-induced vascular smooth muscle cell calcification.
Atherosclerosis. 243:357–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goncharova EA, Ammit AJ, Irani C, Carroll
RG, Eszterhas AJ, Panettieri RA and Krymskaya VP: PI3K is required
for proliferation and migration of human pulmonary vascular smooth
muscle cells. Am J Physiol Lung Cell Mol Physiol. 283:L354–L363.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Salido M, Gonzalez JL and Vilches J: Loss
of mitochondrial membrane potential is inhibited by bombesin in
etoposide-induced apoptosis in PC-3 prostate carcinoma cells. Mol
Cancer Ther. 6:1292–1299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng
X and Zhu D: 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic
responses in pulmonary artery smooth muscle cells. Eur J Pharmacol.
588:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiong Y, Yu Y, Montani JP, Yang Z and Ming
XF: Arginase-II induces vascular smooth muscle cell senescence and
apoptosis through p66Shc and p53 independently of its l-arginine
urea-hydrolase activity: implications for atherosclerotic plaque
vulnerability. J Am Heart Assoc. 2:e0000962013. View Article : Google Scholar
|
|
39
|
Leeper NJ, Raiesdana A, Kojima Y, Kundu
RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, et
al: Loss of CDKN2B promotes p53-dependent smooth muscle cell
apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol.
33:e1-e102013. View Article : Google Scholar :
|
|
40
|
Li W, Huang H, Li L, Wang L, Li Y, Wang Y,
Guo S, Li L, Wang D, He Y, et al: The pathogenesis of
atherosclerosis based on human signaling networks and stem cell
expression data. Int J Biol Sci. 14:1678–1685. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mozaffarian D, Benjamin EJ, Go AS, Arnett
DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP,
Fullerton HJ, et al Writing Group Members: American Heart
Association Statistics Committee; Stroke Statistics Subcommittee:
Heart disease and stroke statistics-2016 update: a report from the
american heart association. Circulation. 133:e38–e360. 2016.
|
|
42
|
Li H, Zhu H and Ge J: Long noncoding RNA:
recent updates in atherosclerosis. Int J Biol Sci. 12:898–910.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nakajima K, Nakano T and Tanaka A: The
oxidative modification hypothesis of atherosclerosis: the
comparison of atherogenic effects on oxidized LDL and remnant
lipoproteins in plasma. Clin Chim Acta. 367:36–47. PubMed/NCBI
|
|
44
|
Johnson JL: Emerging regulators of
vascular smooth muscle cell function in the development and
progression of atherosclerosis. Cardiovasc Res. 103:452–460. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang P, Xu TY, Guan YF, Zhao Y, Li ZY, Lan
XH, Wang X, Yang PY, Kang ZM, Vanhoutte PM, et al: Vascular smooth
muscle cell apoptosis is an early trigger for hypothyroid
atherosclerosis. Cardiovasc Res. 102:448–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Holdt LM, Beutner F, Scholz M, Gielen S,
Gäbel G, Bergert H, Schuler G, Thiery J and Teupser D: ANRIL
expression is associated with atherosclerosis risk at chromosome
9p21. Arterioscler Thromb Vasc Biol. 30:620–627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Congrains A, Kamide K, Oguro R, Yasuda O,
Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, et
al: Genetic variants at the 9p21 locus contribute to
atherosclerosis through modulation of ANRIL and CDKN2A/B.
Atherosclerosis. 220:449–455. 2012. View Article : Google Scholar
|
|
48
|
Hou J, Wang J, Zhang P, Li D, Zhang C,
Zhao H, Fu J, Wang B and Liu J: Baicalin attenuates proinflammatory
cytokine production in oxygen-glucose deprived challenged rat
microglial cells by inhibiting TLR4 signaling pathway. Int
Immunopharmacol. 14:749–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim DH, Cho KH, Moon SK, Kim YS, Kim DH,
Choi JS and Chung HY: Cytoprotective mechanism of baicalin against
endothelial cell damage by peroxynitrite. J Pharm Pharmacol.
57:1581–1590. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yan S, Wang Y, Liu P, Chen A, Chen M, Yao
D, Xu X, Wang L and Huang X: Baicalin attenuates hypoxia-induced
pulmonary arterial hypertension to improve hypoxic cor pulmonale by
reducing the activity of the p38 MAPK signaling pathway and MMP-9.
Evid Based Complement Alternat Med. 2016:25464022016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang B, Liao PP, Liu LH, Fang X, Li W and
Guan SM: Baicalin and geniposide inhibit the development of
atherosclerosis by increasing Wnt1 and inhibiting dickkopf-related
protein-1 expression. J Geriatr Cardiol. 13:846–854.
2016.PubMed/NCBI
|
|
52
|
Bendris N, Lemmers B and Blanchard JM:
Cell cycle, cytoskeleton dynamics and beyond: The many functions of
cyclins and CDK inhibitors. Cell Cycle. 14:1786–1798. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Braun-Dullaeus RC, Mann MJ, Sedding DG,
Sherwood SW, von der Leyen HE and Dzau VJ: Cell cycle-dependent
regulation of smooth muscle cell activation. Arterioscler Thromb
Vasc Biol. 24:845–850. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mayr U, Mayr M, Li C, Wernig F, Dietrich
H, Hu Y and Xu Q: Loss of p53 accelerates neointimal lesions of
vein bypass grafts in mice. Circ Res. 90:197–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sanz-González SM, Barquín L, García-Cao I,
Roque M, González JM, Fuster JJ, Castells MT, Flores JM, Serrano M
and Andrés V: Increased p53 gene dosage reduces neointimal
thickening induced by mechanical injury but has no effect on native
atherosclerosis. Cardiovasc Res. 75:803–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ihling C, Menzel G, Wellens E, Mönting JS,
Schaefer HE and Zeiher AM: Topographical association between the
cyclin-dependent kinases inhibitor P21, p53 accumulation, and
cellular proliferation in human atherosclerotic tissue.
Arterioscler Thromb Vasc Biol. 17:2218–2224. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Scheinman M, Ascher E, Levi GS, Hingorani
A, Shirazian D and Seth P: p53 gene transfer to the injured rat
carotid artery decreases neointimal formation. J Vasc Surg.
29:360–369. 1999. View Article : Google Scholar : PubMed/NCBI
|
